Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Test crawled time : 20:20 save search
Next-Generation Cologuard® Test Demonstrates High Sensitivity and Specificity in Pivotal BLUE-C Study, Significantly Outperforming Fecal Immunochemical Testing (FIT) for Cancer and Precancer Detection
Published: 2023-10-22 (Crawled : 20:20) - prnewswire.com
EXAS | $63.53 1.8% 1.79% 1.3M
|
Health Technology
|
| O: -0.68%
H: 1.76%
C: 0.36%
cologuard test cancer
Landmark CIRCULATE-Japan Study Shows Natera's Signatera™ MRD Test is Predictive of Chemotherapy Benefit in Colorectal Cancer
Published: 2022-01-22 (Crawled : 20:20) - prnewswire.com
NTRA | News M | $91.04 2.74% 2.7% 1.2M
|
Health Services
| Email alert
Add to watchlist
test therapy cancer colorectal cancer
U.S. Food and Drug Administration (FDA) Responds to Request From TherapeuticsMD to Revise Certain Manufacturing Testing Limits for ANNOVERA®
Published: 2021-12-10 (Crawled : 20:20) - ir.therapeuticsmd.com
TXMD | News | $1.88 -0.27% 21K
|
Health Technology
| Email alert
Add to watchlist
annovera fda drug therapeutics food test
New Study Highlights the Value of Genetic Testing to Guide Clinical Management and Improve Outcomes for Epilepsy Patients
Published: 2021-09-25 (Crawled : 20:20) - prnewswire.com
NVTA | News | $0.019 0.0% 22M
|
Health Services
| Email alert
Add to watchlist
genetic test
Sorrento Announces an Independent Real-World Study That Reports Superior Sensitivity Results in Detecting COVID-19 Virus Infections in All-Comer General Population by COVISTIX as Compared to a Globally Leading Rapid Antigen Test
Published: 2021-09-19 (Crawled : 20:20) - globenewswire.com
SRNE | $0.015 -8.85% 56K
|
Health Technology
|
| O: -0.86%
H: 2.09%
C: -0.99%
covid test results injection infections
Lilly Presents New Data on Retevmo® (selpercatinib) in Advanced RET Fusion-Positive Gastrointestinal and Other Cancers at 2021 American Association for Cancer Research (AACR) Annual Meeting
Published: 2021-04-11 (Crawled : 20:20) - prnewswire.com
LLY | News | $745.69 1.96% 0.04% 1.4M
|
Health Technology
|
| O: -0.57%
H: 0.28%
C: -0.88%
test positive cancer gastrointestinal research
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News 4 | $4.6 164.37% 62.17% 26M
|
AGBA | $2.97 137.6% 57.48% 66M
|
Finance
EDBL | News | $6.59 75.27% 41.8% 2M
|
ZAPP | $4.44 50.2% 33.12% 370K
|
n/a
MTC | $2.24 43.59% 30.67% 6M
|
Technology Services
OPRT | News | $3.15 40.0% 29.13% 12M
|
Finance
SHIM | $3.045 35.33% 26.23% 870K
|
HKIT | $1.33 30.39% 24.16% 390K
|
Technology Services
ABVC | $1.35 29.81% 23.53% 7.1M
|
Wholesale Trade
OST | $0.5 25.0% 21.88% 280K
|
Your saved searches
Save your searches and get alerts when important news are released.